Benzinga | Nov 19, 2021 05:03PM EST

Acer Therapeutics Q3 EPS $(0.23) Up From $(0.51) YoY

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.23) per share. This is a 54.9 percent increase over losses of $(0.51) per share from the same period last year.